Submitted by Anonymous (not verified) on 14 January 2026 - 13:25
Human medicines European public assessment report (EPAR): Rydapt, midostaurin, Date of authorisation: 18/09/2017, Revision: 14, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Rydapt, midostaurin, Date of authorisation: 18/09/2017, Revision: 14, Status: Authorised